Psoriasis and Depression: The Role of Inflammation

A Meta-Analysis of Cytokines in Major Depression

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., & Lanctôt, K. L. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.033 · Cited by 4,729 · see citing works

Cytokines sing the blues: inflammation and the pathogenesis of depression

Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009 · see citing works

The relationship between social support and physiological processes: A review with emphasis on underlying mechanisms and implications for health.

Uchino, B. N., Cacioppo, J. T., & Kiecolt-Glaser, J. K. (1996) · Psychological Bulletin · doi:10.1037/0033-2909.119.3.488 · Cited by 2,727 · see citing works

Inflammatory Blockade Restores Adult Hippocampal Neurogenesis

Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426 · see citing works

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N. M., Guzzo, C. A., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,870 · see citing works

A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression: The Role of Baseline Inflammatory Biomarkers

Raison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · see citing works

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

Papp, K. A., Langley, R. G. B., Lebwohl, M., Krueger, G. G., Szapary, P. O., Yeilding, N. M., Guzzo, C. A., Hsu, M.-C., Wang, Y., Li, S., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60726-6 · Cited by 1,358 · see citing works

Guidelines of care for the management of psoriasis and psoriatic arthritis

Menter, A., Gottlieb, A. B., Feldman, S. R., Voorhees, A. S. V., Leonardi, C. L., Gordon, K. B., Lebwohl, M., Koo, J. Y. M., Elmets, C. A., Korman, N. J., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.039 · Cited by 1,220 · see citing works

Immune system to brain signaling: Neuropsychopharmacological implications

Capuron, L., & Miller, A. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.014 · Cited by 1,195 · see citing works

Etanercept as Monotherapy in Patients with Psoriasis

Leonardi, C. L., POWERS, J. L., Matheson, R. T., Goffe, B. S., Zitnik, R. J., Wang, A., & Gottlieb, A. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030409 · Cited by 1,173 · see citing works

Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial

Tyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · see citing works

Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial

Reich, K., Nestle, F. O., Papp, K. A., Ortonne, J. P., Evans, R., Guzzo, C. A., Li, S., Dooley, L. T., & Griffiths, C. E. M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67566-6 · Cited by 1,045 · see citing works

CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies.

Valkanova, V., Ebmeier, K. P., & Allan, C. L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.004 · Cited by 972 · see citing works

Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis

Gupta, M., & Gupta, A. K. (1998) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1998.02511.x · Cited by 927 · see citing works

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial

Menter, A., Tyring, S. K., Gordon, K. B., Kimball, A. B., Leonardi, C. L., Langley, R. G. B., Strober, B. E., Kaul, M., Gu, Y., Okun, M. M., et al. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 886 · see citing works

Inflammation: Depression Fans the Flames and Feasts on the Heat

Kiecolt-Glaser, J. K., Derry, H. M., & Fagundes, C. P. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15020152 · Cited by 844 · see citing works

National Trends in the Outpatient Treatment of Depression

Olfson, M. (2002) · JAMA · doi:10.1001/jama.287.2.203 · Cited by 834 · see citing works

Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials

Griffiths, C. E. M., Reich, K., Lebwohl, M., van de Kerkhof, P., Paul, C., Menter, A., Cameron, G. S., Erickson, J., Zhang, L., Secrest, R. J., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60125-8 · Cited by 834 · see citing works

The Risk of Depression, Anxiety, and Suicidality in Patients With Psoriasis

Chosidow, O., ROBERT, P. D., DAIHUNG, D., URBÀ, G., CATALIN, M. P., Hywel, W., Kurd, S. K., Troxel, A. B., Crits-Christoph, P. F., & Gelfand, J. M. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.186 · Cited by 646 · see citing works

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Reich, K., Papp, K. A., Blauvelt, A., Tyring, S. K., Sinclair, R. D., Thaçi, D., Nograles, K. E., Mehta, A., Cichanowitz, N., Li, Q., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31279-5 · Cited by 570 · see citing works

A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis

Menter, A., Feldman, S. R., Weinstein, G. D., Papp, K. A., Evans, R. J., Guzzo, C. A., Li, S., Dooley, L. T., Arnold, C. M., & Gottlieb, A. B. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.07.017 · Cited by 516 · see citing works

Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis

Papp, K. A., Blauvelt, A., Bukhalo, M., Gooderham, M., Krueger, J. G., Lacour, J. ‐., Menter, A., Philipp, S., Sofen, H. L., Tyring, S. K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607017 · Cited by 514 · see citing works

A prospective phase III, randomized, double‐blind, placebo‐controlled study of brodalumab in patients with moderate‐to‐severe plaque psoriasis

Papp, K. A., Reich, K., Paul, C. F., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R. G. B., Cather, J. C., Gottlieb, A. B., et al. (2016) · British Journal of Dermatology · doi:10.1111/bjd.14493 · Cited by 471 · see citing works

The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis

Dowlatshahi, E. A., Wakkee, M., Arends, L. R., & Nijsten, T. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.508 · Cited by 436 · see citing works

Depression: an inflammatory illness?: Figure 1

Krishnadas, R., & Cavanagh, J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301779 · Cited by 392 · see citing works

STAR*D: What Have We Learned?

Rush, A. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.201 · Cited by 353 · see citing works

Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double‐blind, phase III NAVIGATE trial

Langley, R. G. B., Tsai, T., Flavin, S. K., Song, M., Randazzo, B. P., Wasfi, Y. S., Jiang, J., Li, S., & Puig, L. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15750 · Cited by 341 · see citing works

Depression and immunity: A role for T cells?

Miller, A. H. (2009) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2009.09.009 · Cited by 340 · see citing works

Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study

Blauvelt, A., Reich, K., Tsai, T., Tyring, S. K., Vanaclocha, F., Kingo, K., Ziv, M., Pinter, A., Vender, R. B., Hugot, S., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.08.008 · Cited by 311 · see citing works

Interferon-Induced Depression in Chronic Hepatitis C: A Systematic Review and Meta-Analysis

Udina, M., Castellví, P., Moreno-España, J., Navinés, R., Valdés, M., Forns, X., Langohr, K., Solà, R., Vieta, E., & Martín-Santos, R. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.12r07694 · Cited by 297 · see citing works

The contribution of perceptions of stigmatisation to disability in patients with psoriasis

Richards, H. L., Fortune, D. G., Griffiths, C. E. M., & Main, C. J. (2001) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(00)00210-5 · Cited by 295 · see citing works

TNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation

Bélarbi, K., Jopson, T. D., Tweedie, D., Arellano, C., Luo, W., Greig, N. H., & Rosi, S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-23 · Cited by 285 · see citing works

Patients with Psoriasis Feel Stigmatized

Szepietowski, J. C., Hrehorów, E., Salomon, J., Matusiak, Ł., & Reich, A. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1193 · Cited by 281 · see citing works

Inflammation and Specific Symptoms of Depression

Jokela, M. M., Virtanen, M., Batty, G. D., & Mika Kivimaki, B. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1977 · Cited by 261 · see citing works

The impact of major depressive disorder on the short‐ and long‐term outcome of Crohn's disease treatment with infliximab

PERSOONS, P., VERMEIRE, S., DEMYTTENAERE, K., FISCHLER, B., VANDENBERGHE, J., VAN OUDENHOVE, L., PIERIK, M., HLAVATY, T., VAN ASSCHE, G., NOMAN, M., et al. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02535.x · Cited by 253 · cited 1× · see citing works

Depression and anxiety in psoriatic disease: prevalence and associated factors

McDonough, E., Ayearst, R., Eder, L., Chandran, V., Rosen, C. F., Thavaneswaran, A., & Gladman, D. D. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130797 · Cited by 250 · see citing works

An Italian Study on Psoriasis and Depression

Esposito, M., Saraceno, R., Giunta, A., Maccarone, M., & Chimenti, S. (2006) · Dermatology · doi:10.1159/000090652 · Cited by 249 · see citing works

Psychologic Factors in Psoriasis: Consequences, Mechanisms, and Interventions

Fortune, D. G., Richards, H. L., & Griffiths, C. E. M. (2005) · Dermatologic Clinics · doi:10.1016/j.det.2005.05.022 · Cited by 243 · see citing works

Cytokines, stress, and depressive illness

Anisman, H., & Merali, Z. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00009-0 · Cited by 225 · see citing works

Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial

Langley, R. G. B., Feldman, S. R., Han, C., Schenkel, B., Szapary, P. O., Hsu, M.-C., Ortonne, J. P., Gordon, K. B., & Kimball, A. B. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.09.014 · Cited by 218 · see citing works

Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration

Ohgi, Y., Futamura, T., Kikuchi, T., & Hashimoto, K. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.003 · Cited by 208 · see citing works

The effect of adalimumab on reducing depression symptoms in patients with moderate to severe psoriasis: A randomized clinical trial

Menter, A., Augustin, M., Signorovitch, J., Yu, A. P., Wu, E. Q., Gupta, S. R., Bao, Y., & Mulani, P. M. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.07.022 · Cited by 197 · see citing works

A critical review of human endotoxin administration as an experimental paradigm of depression.

DellaGioia, N., & Hannestad, J. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.07.014 · Cited by 175 · see citing works

Role of Depression in Quality of Life for Patients with Psoriasis

Schmitt, J. M., & Ford, D. E. (2007) · Dermatology · doi:10.1159/000102029 · Cited by 167 · see citing works

Psychoneuroimmunology

Tausk, F., Elenkov, I. J., & Moynihan, J. A. (2008) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2008.00166.x · Cited by 165 · see citing works

Efficacy and safety of adalimumab across subgroups of patients with moderate to severe psoriasis

Menter, A., Gordon, K. B., Leonardi, C. L., Gu, Y., & Goldblum, O. M. (2010) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.09.040 · Cited by 164 · see citing works

Successful treatment of moderate to severe plaque psoriasis with the PEGylated Fab′ certolizumab pegol: results of a phase II randomized, placebo-controlled trial with a re-treatment extension

Reich, K., Ortonne, J. ‐., Gottlieb, A. B., Terpstra, I. J., Coteur, G., Tasset, C. T., & Mease, P. J. (2012) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2012.10941.x · Cited by 156 · see citing works

Inflammatory and Neurodegenerative Pathways in Depression: A New Avenue for Antidepressant Development?

Catena-Dell’Osso, M., Bellantuono, C., Consoli, G., Baroni, S., Rotella, F., & Marazziti, D. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794088353 · Cited by 149 · see citing works

Better medication adherence results in greater improvement in severity of psoriasis

Carroll, C. L., Feldman, S. R., CAMACHO, F. T., & Balkrishnan, R. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.06174.x · Cited by 145 · see citing works

The Involvement of TNF-α in Cognitive Dysfunction Associated with Major Depressive Disorder: An Opportunity for Domain Specific Treatments

Bortolato, B., F. Carvalho, A., K. Soczynska, J., I. Perini, G., & S. McIntyre, R. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666150630171433 · Cited by 142 · see citing works

SYNERGISTIC RELATIONSHIPS AMONG STRESS, DEPRESSION, AND TROUBLED RELATIONSHIPS: INSIGHTS FROM PSYCHONEUROIMMUNOLOGY

Jaremka, L. M., Lindgren, M. E., & Kiecolt‐Glaser, J. K. (2013) · Depression and Anxiety · doi:10.1002/da.22078 · Cited by 137 · see citing works

Consensus document on the evaluation and treatment of moderate‐to‐severe psoriasis: Psoriasis Group of the Spanish Academy of Dermatology and Venereology

Daudén, E., Puig, L., Ferrándiz, C., Sánchez‐Carazo, J. L., & Hermosa, J. M. H. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13542 · Cited by 134 · see citing works

Improvement in quality of life with infliximab induction and maintenance therapy in patients with moderate-to-severe psoriasis: a randomized controlled trial

Reich, K., Nestle, F. O., Papp, K. A., Ortonne, J. ‐., Wu, Y., BALA, M. M., Evans, R., Guzzo, C. A., Li, S., Dooley, L. T., et al. (2006) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2006.07237.x · Cited by 131 · see citing works

Economic burden of comorbidities in patients with psoriasis is substantial

Kimball, A. B., Guérin, A., Tsaneva, M., Yu, A., Wu, E., Gupta, S., Bao, Y., & Mulani, P. M. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2010.03730.x · Cited by 122 · see citing works

Effects of etanercept therapy on fatigue and symptoms of depression in subjects treated for moderate to severe plaque psoriasis for up to 96 weeks

Krishnan, R. R., Cella, D. F., Leonardi, C., Papp, K. A., Gottlieb, A. B., Dunn, M. E., Chiou, C. F., Patel, V. D., & Jahreis, A. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.08205.x · Cited by 121 · see citing works

Cytokines as a stressor: implications for depressive illness

Anisman, H., Hayley, S. P., Turrin, N. P., & Merali, Z. (2002) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145702003097 · Cited by 106 · see citing works

Effect of biologics on depressive symptoms in patients with psoriasis: a systematic review

Fleming, P., Roubille, C., Richer, V., Starnino, T., McCourt, C., McFarlane, A., Siu, S., Kraft, J. N., Lynde, C. W., Pope, J. E., et al. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12909 · Cited by 104 · see citing works

Acetylsalicylic acid accelerates the antidepressant effect of fluoxetine in the chronic escape deficit model of depression

Brunello, N., Alboni, S., Capone, G., Benatti, C., Blom, J. M. C., Tascedda, F., Kriwin, P., & Mendlewicz, J. (2006) · International Clinical Psychopharmacology · doi:10.1097/00004850-200607000-00004 · Cited by 104 · see citing works

Understanding the relationship between objective disease severity, psoriatic symptoms, illness-related stress, health-related quality of life and depressive symptoms in patients with psoriasis — a structural equations modeling approach

Schmitt, J. M., & Ford, D. E. (2007) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2006.12.004 · Cited by 94 · see citing works

Infliximab improves health-related quality of life in the presence of comorbidities among patients with moderate-to-severe psoriasis

Feldman, S. R., Gottlieb, A. B., BALA, M. M., Wu, Y., Eisenberg, D. F., Guzzo, C. A., Li, S., Dooley, L. T., & Menter, A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08727.x · Cited by 86 · see citing works

Adalimumab treatment is associated with improvement in health‐related quality of life in psoriasis: Patient‐reported outcomes from a Phase II randomized controlled trial

Shikiar, R., Heffernan, M. P., Langley, R. G. B., Willian, M. K., Okun, M. M., & Revicki, D. A. (2007) · Journal of Dermatological Treatment · doi:10.1080/09546630601121060 · Cited by 84 · see citing works

Etanercept improves the health-related quality of life of patients with psoriasis: Results of a phase III randomized clinical trial

Feldman, S. R., Kimball, A. B., Krueger, G. G., Woolley, J. M., Lalla, D., & Jahreis, A. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2005.06.053 · Cited by 83 · see citing works

Exploring the Physiological Link between Psoriasis and Mood Disorders

Connor, C. J., Liu, V., & Fiedorowicz, J. G. (2015) · Dermatology Research and Practice · doi:10.1155/2015/409637 · Cited by 83 · see citing works

Pruritus and quality of life in moderate‐to‐severe plaque psoriasis: post hoc explorative analysis from the PRISTINE study

Mrowietz, U., Chouela, E. N., Mallbris, L., Stefanidis, D., Marino, V., Pedersen, R. D., & Boggs, R. L. (2014) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12761 · Cited by 81 · see citing works

Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities

Kimball, A. B., Bensimon, A. G., Guérin, A., Yu, A. P., Wu, E. Q., Okun, M. M., Bao, Y., Gupta, S. R., & Mulani, P. M. (2010) · American Journal of Clinical Dermatology · doi:10.2165/11530640-000000000-00000 · Cited by 64 · see citing works

Mind and body: how the health of the body impacts on neuropsychiatry

Renoir, T., Hasebe, K., & Gray, L. J. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00158 · Cited by 62 · see citing works

Patient-Reported Outcomes and Health-Care Resource Utilization in Patients with Psoriasis Treated with Etanercept: Continuous versus Interrupted Treatment

Gelfand, J. M., Kimball, A. B., Mostow, E. N., Chiou, C., Patel, V. D., Xia, H. A., Freundlich, B., & Stevens, S. R. (2007) · Value in Health · doi:10.1111/j.1524-4733.2007.00251.x · Cited by 61 · see citing works

Adverse effects with long-term cyclosporin for severe psoriasis

Markham, T., Watson, A., & Rogers, S. (2002) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2002.00998.x · Cited by 58 · see citing works

Discapacidad acumulada en el transcurso vital: la cicatriz de la psoriasis en la vida del paciente

Ros, S., Puig, L., & Carrascosa, J. M. (2013) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2013.02.009 · Cited by 53 · see citing works

Adalimumab improves health-related quality of life in patients with moderate to severe plaque psoriasis compared with the United States general population norms: Results from a randomized, controlled Phase III study

Revicki, D. A., Menter, A., Feldman, S. R., Kimel, M., Harnam, N., & Willian, M. K. (2008) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-6-75 · Cited by 43 · see citing works

Tumor necrosis factor alpha and adalimumab differentially regulate CD36 expression in human monocytes

Boyer, J., Balard, P., Authier, H., Faucon, B., Bernad, J., Mazières, B., Davignon, J., Cantagrel, A. G., Pipy, B., & Constantin, A. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2133 · Cited by 41 · see citing works

Medication and health care service utilization related to depressive symptoms in older adults with psoriasis

Kulkarni, A. S., Balkrishnan, R., CAMACHO, F. T., Anderson, R. T., & Feldman, S. R. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.10.773 · Cited by 40 · see citing works

Mental Health Self-Assessment in Patients With Moderate to Severe Psoriasis: An Observational, Multicenter Study of 1164 Patients in Spain (The VACAP Study)

Pujol, R. M., Puig, L., Daudén, E., Sánchez‐Carazo, J. L., Toribio, J., Vanaclocha, F., Yébenes, M., Sabater, E., Casado, M. Á., Caloto, M. T., et al. (2013) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2013.04.014 · Cited by 35 · see citing works

Rapid improvements in health‐related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER ‐2 and UNCOVER ‐3

Leonardi, C., Blauvelt, A., Sofen, H. L., Gooderham, M., Augustin, M., Burge, R. T., Zhu, B., & Reich, K. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14211 · Cited by 34 · see citing works

Apremilast, an oral phosphodiesterase 4 inhibitor, improves patient‐reported outcomes in the treatment of moderate to severe psoriasis: results of two phase III randomized, controlled trials

Thaçi, D., Kimball, A. B., Foley, P. A., Poulin, Y. P., Levi, E., Chen, R., & Feldman, S. R. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13918 · Cited by 32 · see citing works

Comorbidity and its relevance on general hospital based mortality in major depressive disorder: A naturalistic 12-year follow-up in general hospital admissions

Schoepf, D., Uppal, H., Potluri, R., CHANDRAN, S. R., & Heun, R. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.01.010 · Cited by 30 · see citing works

The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis

Frieder, J., Kivelevitch, D. N., Fiore, C. T., Saad, S. S., & Menter, A. (2017) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2018.1401468 · Cited by 27 · see citing works

The Role of Psychoneuroimmunology in Personalized and Systems Medicine

Yan, Q. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-071-7_1 · Cited by 20 · see citing works

Autoevaluación de salud mental en pacientes con psoriasis moderada a grave: un estudio multicéntrico observacional de 1.164 pacientes en España (el estudio VACAP)

Pujol, R. M., Puig, L., Tello, E. D., Carazo, J. L. S., Pérez, J. T., Sebastián, F. V., Yébenes, M., Cabrera, E. S., Casado, M. A., González, M. T., et al. (2013) · Actas Dermo-Sifiliográficas · Cited by 15 · see citing works

Psoriasis y comorbilidad psiquiátrica: la próxima frontera

Carrascosa, J. M., & Ballescá, F. (2017) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2017.04.001 · Cited by 7 · see citing works

The broad autism phenotype: A complementary strategy for molecular genetic studies of autism

(2001) · doi:10.1002/1096-8628(20010108)105:1

Signaling pathways and targeted therapies for psoriasis

Guo, J., Zhang, H., Lin, W., Lu, L., Su, J., & Chen, X. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01655-6 · Cited by 455 · see citing works

C-Reactive protein as a biomarker for major depressive disorder?

Orsolini, L., Pompili, S., Tempia Valenta, S., Salvi, V., & Volpe, U. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031616 · Cited by 171 · see citing works

The Brain–Skin Axis in Psoriasis—Psychological, Psychiatric, Hormonal, and Dermatological Aspects

Marek‐Józefowicz, L., Czajkowski, R., Borkowska, A., Nedoszytko, B., Zmijewski, M. A., Cubała, W. J., & Slominski, A. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020669 · Cited by 161 · see citing works

Lipid-based nanoparticles for psoriasis treatment: a review on conventional treatments, recent works, and future prospects

Nordin, U. U. M., Ahmad, N., Salim, N., & Yusof, N. M. M. (2021) · RSC Advances · doi:10.1039/d1ra06087b · Cited by 78 · see citing works

Dysregulation of the gut-brain-skin axis and key overlapping inflammatory and immune mechanisms of psoriasis and depression

Wang, X., Li, Y., Wu, L., Xiao, S., Ji, Y., Tan, Y., Jiang, C., & Zhang, G. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111065 · Cited by 95 · see citing works

Emerging role of the cGAS-STING signaling pathway in autoimmune diseases: Biologic function, mechanisms and clinical prospection

Hu, Y., Chen, B., Yang, F., Su, Y., Yang, D., Yao, Y., Wang, S., Wu, Y., Tao, L., & Xu, T. (2022) · Autoimmunity Reviews · doi:10.1016/j.autrev.2022.103155 · Cited by 92 · see citing works

Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases

Yuan, C., He, Y., Xie, K., Feng, L., Gao, S., & Cai, L. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1282431 · Cited by 82 · see citing works

A systematic review on shared biological mechanisms of depression and anxiety in comorbidity with psoriasis, atopic dermatitis, and hidradenitis suppurativa

Fabrazzo, M., Cipolla, S., Signoriello, S., Camerlengo, A., Calabrese, G., Giordano, G. M., Argenziano, G., & Galderisi, S. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.2249 · Cited by 78 · see citing works

Tackling the various classes of nano-therapeutics employed in topical therapy of psoriasis

Fereig, S. A., El-Zaafarany, G. M., Arafa, M. G., & Abdel-Mottaleb, M. M. A. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1754527 · Cited by 70 · see citing works

Assessing and Improving Psychological Well-Being in Psoriasis: Considerations for the Clinician

Blackstone, B., Patel, R., & Bewley, A. (2022) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s328447 · Cited by 69 · see citing works

Comorbidity in Adult Psoriasis: Considerations for the Clinician

Daugaard, C. A., Iversen, L., & Hjuler, K. F. (2022) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s328572 · Cited by 62 · see citing works

Alantolactone-loaded chitosan/hyaluronic acid nanoparticles suppress psoriasis by deactivating STAT3 pathway and restricting immune cell recruitment

Chen, R., Zhai, Y., Sun, L., Wang, Z., Xia, X., Yao, Q., & Kou, L. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.02.003 · Cited by 58 · see citing works

Relationship between Immune Cells, Depression, Stress, and Psoriasis: Could the Use of Natural Products Be Helpful?

Alesci, A., Lauriano, E. R., Fumia, A., Irrera, N., Mastrantonio, E., Vaccaro, M., Gangemi, S., Santini, A., Cicero, N., & Pergolizzi, S. (2022) · Molecules · doi:10.3390/molecules27061953 · Cited by 59 · see citing works

New Topical Therapies for Psoriasis

Lé, A. M., & Torres, T. R. (2021) · American Journal of Clinical Dermatology · doi:10.1007/s40257-021-00649-w · Cited by 54 · see citing works

Mutual Relationship Between Sleep Disorders, Quality of Life and Psychosocial Aspects in Patients With Psoriasis

Nowowiejska, J., Baran, A. M., & Flisiak, I. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.674460 · Cited by 39 · see citing works

The Effectiveness and Safety of Probiotic Supplements for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials and Preclinical Trials

Zeng, L., Yu, G., Wu, Y., Hao, W., & Chen, H. (2021) · Journal of Immunology Research · doi:10.1155/2021/7552546 · Cited by 39 · see citing works

Biologic Therapies Decrease Disease Severity and Improve Depression and Anxiety Symptoms in Psoriasis Patients

Timiș, T. L., Beni, L., Mocan, T., Florian, I. A., & Orăsan, R.-I. (2023) · Life · doi:10.3390/life13051219 · Cited by 30 · see citing works

Association of psoriasis with depression, anxiety, and suicidality: A bidirectional two‐sample Mendelian randomization study

Chu, M., Shen, S., Zhu, Z., Li, Z., Bai, Y., Ma, J., Hao, J., Wang, L., Fu, M., Dang, E., et al. (2023) · The Journal of Dermatology · doi:10.1111/1346-8138.16941 · Cited by 29 · see citing works

Role of Serotonin and Dopamine in Psoriasis: A Case-Control Study

Wardhana, M., Windari, M., Puspasari, N., & Suryawati, N. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.267 · Cited by 27 · see citing works

Depressive-like behaviors in mice with Imiquimod-induced psoriasis

Guo, J., Liu, Y., Guo, X., Meng, Y., Qi, C., Zhao, J., Di, T., Zhang, L., Guo, X., Wang, Y., et al. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107057 · Cited by 27 · see citing works

Sex and Age Influence the Associated Risk of Depression in Patients with Psoriasis: A Retrospective Population Study Based on Diagnosis and Drug-Use

Duvetorp, A., Mrowietz, U., Nilsson, M., & Seifert, O. (2020) · Dermatology · doi:10.1159/000509732 · Cited by 27 · see citing works

Application of Genetic Algorithm‐Based Support Vector Machine in Identification of Gene Expression Signatures for Psoriasis Classification: A Hybrid Model

Tapak, L., Afshar, S., Afrasiabi, M., Ghasemi, M. K., & Alirezaei, P. (2021) · BioMed Research International · doi:10.1155/2021/5520710 · Cited by 23 · see citing works

Association of Psoriasis With Anxiety and Depression: A Case–Control Study in Chinese Patients

Jing, D., Xiao, H., Shen, M., Chen, X., Han, X., Kuang, Y., Zhu, W., & Xiao, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.771645 · Cited by 20 · see citing works

Effects of different concentrations of human umbilical cord mesenchymal stem cells to ameliorate psoriasis-like skin lesions in BALB/c mice

Lin, Y., Wang, H., Jiang, C., Chen, C., Shen, D., Xie, F., Zhang, H., Yang, J., & Wang, H. (2022) · Annals of Translational Medicine · doi:10.21037/atm-22-4 · Cited by 19 · see citing works

Sobriety and Satiety: Is NAD+ the Answer?

Braidy, N., Villalva, M. D., & van Eeden, S. (2020) · Antioxidants · doi:10.3390/antiox9050425 · Cited by 17 · see citing works

Aspectos gerais da psoríase: revisão narrativa

Vilefort, L. A., Silva, H. S. E., Vilela, L. C., Tanaka, V. Y. T., Vianna, R. M., de Sá, Y. A., Lisbôa, A. C. C., de Oliveira, M. S., Duarte, A. C. S., & Rezende, O. G. M. (2022) · Revista Eletrônica Acervo Científico · doi:10.25248/reac.e10310.2022 · Cited by 14 · see citing works

Efficacy of psychological intervention for patients with psoriasis vulgaris: a prospective study

Li, X., Liu, L., Zhang, Y., & Li, L. (2020) · Journal of International Medical Research · doi:10.1177/0300060520961674 · Cited by 13 · see citing works

Altered brain activity and cognitive impairment in patients with psoriasis

Yi, X., Wang, X., Fu, Y. H. H., Luo, Y., Wang, J., Han, Z., Kuang, Y., Chen, X., & Chen, B. T. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19685 · Cited by 13 · see citing works

Defining well-being in psoriasis: A Delphi consensus among healthcare professionals and patients

Daudén, E., Belinchón, I., Colominas-González, E., Coto, P., de la Cueva, P., Gallardo, F., Poveda, J. L., Herráiz, E. R., Ros, S., Ruíz‐Villaverde, R., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-64738-6 · Cited by 12 · see citing works

Effectiveness of Long-Term Treatment with Brodalumab on Anxiety or Depressive Symptoms in Japanese Patients with Psoriasis: The ProLOGUE Study

Ohata, C., Kanai, Y., Murotani, K., Yamazaki, F., Takahashi, H., Tada, Y., Mabuchi, T., Mizutani, Y., Nomura, T., & Imafuku, S. (2023) · Dermatology and Therapy · doi:10.1007/s13555-023-00909-z · Cited by 12 · see citing works

Cognitive Functions Associated with Brain Imaging Markers in Patients with Psoriasis

Marek‐Józefowicz, L., Lemanowicz, A., Grochocka, M., Wroblewska, M., Białczyk, K., Piec, K., Kozera, G., Serafin, Z., Czajkowski, R., & Borkowska, A. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19095687 · Cited by 11 · see citing works

Atopic Dermatitis beyond Eczema: A Review on its Systemic Impact through Pruritus and Associated Comorbidities

Prados‐Carmona, Á., Husein‐ElAhmed, H., Navarro‐Triviño, F. J., & Ruíz‐Villaverde, R. (2025) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-025-09075-w · Cited by 10 · see citing works

Unmet Needs in the Management of Moderate-to-Severe Psoriasis in Spain: A Multidimensional Evaluation

Zozaya, N., Villoro, R., Abdalla, F., Zamora, S. A., Filgueiras, J. B., Carrascosa, J. M., Sánchez, O. D., Sinisterra, F. D., Ruíz, A., Herranz, P., et al. (2022) · Acta Dermato Venereologica · doi:10.2340/actadv.v102.583 · Cited by 10 · see citing works

Fisiopatologia da psoríase e seus aspectos imunológicos: uma revisão sistemática

Castilho, A. C. D. S., Lopes, C. D. O. P., & Salles, B. C. C. (2021) · Research Society and Development · doi:10.33448/rsd-v10i11.19346 · Cited by 10 · see citing works

A Systematic Review with Meta-Analysis of Comparative Efficacy and Safety of Risankizumab and Ustekinumab for Psoriasis Treatment

Yu, Q., Ge, X., Jing, M., Mi, X., Guo, J., Xiao, M., Qing, L., & Chen, M. (2022) · Journal of Immunology Research · doi:10.1155/2022/2802892 · Cited by 9 · see citing works

Infection risk in psoriatic patients receiving tumour necrosis factor inhibitors: a 20‐year systematic review and meta‐analysis of randomized controlled trials

Wang, Y. ‐., Lin, Y. ‐., Ma, S., Chang, Y. ‐., & Chen, C. ‐. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18407 · Cited by 8 · see citing works

Transcriptome Analysis Identifies Biomarkers for the Diagnosis and Management of Psoriasis Complicated with Depression

Xia, X., Yu, H., Li, Y., Liang, Y., Li, G., & Huang, F. (2023) · Clinical Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s413887 · Cited by 8 · see citing works

Depression and Anxiety in Patients with Psoriasis: A Comprehensive Analysis Combining Bibliometrics, Latent Dirichlet Allocation, and HJ-Biplot

Siteneski, A., Escobar, K. M., de la Hoz-M, J., Lapo‐Talledo, G. J., Moreno, G. G., Chávez, E. L. C., Caicedo–Quiroz, R., & Borja-Cabrera, G. P. (2025) · Healthcare · doi:10.3390/healthcare13050441 · Cited by 5 · see citing works

Monitoring the psychopathological profile of inflammatory bowel disease patients treated with biological agents: a pilot study

D’Onofrio, A. M., Balzoni, L. M., Ferrajoli, G. F., Vincenzo, F. D., Napolitano, D., Schiavoni, E., Kotzalidis, G. D., Simonetti, A., Mazza, M., Rosa, I., et al. (2024) · Minerva Gastroenterology · doi:10.23736/s2724-5985.24.03719-7 · Cited by 5 · see citing works

Can Biologic Agents Improve Treatment Success in Obese Patients With Psoriasis Vulgaris: A Retrospective Review of 320 Patients With Psoriasis Vulgaris

Avcı, A., Avcı, D., Ulaş, Y., & Ertaş, R. (2024) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1401a58 · Cited by 5 · see citing works

Mononuclear subsets and cytokine profile of venous and capillary blood in patients with psoriasis and healthy people

Sennikova, S. V., Топтыгина, А. П., Semikina, E. L., Шакирович, З. Р., & Akulova, S. S. (2021) · Medical Immunology (Russia) · doi:10.15789/1563-0625-msa-2391 · Cited by 5 · see citing works

Application of bioinformatics analysis and molecular docking to study the mechanism of Qingying decoction in treating psoriasis

Shen, C., Liu, X., Jia, H., Wang, W., Wang, X., Wang, H., Wang, D., & Li, J. (2025) · Hereditas · doi:10.1186/s41065-025-00421-8 · Cited by 4 · see citing works

Clinical features and effects of cyclosporine in the treatment of psoriasis: a systemic review and meta-analysis

Li, Z., Pei, B., Lei, T., Yao, M., Niu, Y., Zhou, P., Lu, Y., & Tang, Y. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03425-y · Cited by 3 · see citing works

Efficacy of treatment of patients with psoriasis with anxiety and depression with interleukin‑23 inhibitor guselkumab

Владимирова, И. С., Kruglova, L. S., Sviridov, O. V., & Samushiya, M. A. (2023) · Medical alphabet · doi:10.33667/2078-5631-2023-24-28-35 · Cited by 3 · see citing works

Exploring the Therapeutic Effects of Anisole on Psoriasis in Mice Based on the JAK1 / STAT3 Pathway

Ning, Q. X., Yue, Y., Liu, X., Ji, W., Zhao, Q. P., Wang, J., & Zhang, Z. (2025) · Phytotherapy Research · doi:10.1002/ptr.8426 · Cited by 3 · see citing works

A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis

Chen, Y., Feng, J., & Gao, A. (2023) · Medicine · doi:10.1097/md.0000000000034859 · Cited by 3 · see citing works

Anogenital pruritus is associated with anxiety, depression, and other psychiatric disorders

Balfour, A., & Kraus, C. N. (2024) · International Journal of Women’s Dermatology · doi:10.1097/jw9.0000000000000168 · Cited by 2 · see citing works

Ginsenoside compound K inhibits oxidative stress and NLRP3 inflammasome activity in mice exposed to chronic unpredictable mild stress

Wu, S., Li, G., Tang, Y. C., Wei, L., Song, D., Wang, X., Zhang, C., Jin, X., & Jiang, S. (2019) · Biotechnology & Biotechnological Equipment · doi:10.1080/13102818.2019.1668851 · Cited by 2 · see citing works

Evaluating Risk Factors for Cumulative Life Course Impairment in Psoriasis using Patient-Acceptable Symptom State and European Quality of Life 5 Dimensions (EQ-5D)

Chularojanamontri, L., Wongpraparut, C., Silpa‐archa, N., Chaiyabutr, C., Wongdama, S., & Chiowchanwisawakit, P. (2023) · Siriraj Medical Journal/San Sirirat · doi:10.33192/smj.v75i9.260756 · Cited by 1 · see citing works

May high mobility group box protein-1 be a biomarker for major depressive disorder?

Kose, A., Turan, T., & Kılıç, E. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578466 · Cited by 2 · see citing works

Challenges and Opportunities in Psoriatic Disease: An Integrated View of the Future

Chinchay, L., Song, K., Stark, J. L., Ward, N. L., & McInnes, I. B. (2025) · The Journal of Rheumatology · doi:10.3899/jrheum.2025-0264 · Cited by 1 · see citing works

The association between psoriasis and suicide

Ghani, H., Tan, I. J., Abramowitz, C., Meledathu, S., Jafferany, M., Vasile, G., & Stamu‐O’Brien, C. (2023) · Dermatological Reviews · doi:10.1002/der2.209 · Cited by 1 · see citing works

Determinants and Correlates of Depression in Psoriasis Patients: Does Marital Adjustment Play a Role?

Sharma, D., Jilani, A. Q., & Sharma, P. (2024) · Indian Journal of Private Psychiatry · doi:10.5005/jp-journals-10067-0159 · Cited by 1 · see citing works

[Artículo traducido] Descripción de los patrones de multimorbilidad de la psoriasis mediante análisis de redes

Almenara‐Blasco, M., Carmona‐Pírez, J., Gracia‐Cazaña, T., Poblador‐Plou, B., Laguna-Berna, C., Juste, A. M., Navarro‐Bielsa, A., Miguel, A. G., & Gilaberte, Y. (2025) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2025.05.005 · Cited by 1 · see citing works

Association between gut microbiota and psoriasis: a bidirectional two-sample Mendelian randomization studyPreprint

Zhang, J., Xiang, Y., Shen, Y., Chen, J., Liu, L., Liu, Q., Jin, J., & Zhu, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3251626/v1 · Cited by 1 · see citing works

ĐẶC ĐIỂM LÂM SÀNG RỐI LOẠN TRẦM CẢM Ở NGƯỜI BỆNH VẢY NẾN ĐIỀU TRỊ TẠI BỆNH VIỆN DA LIỄU TRUNG ƯƠNG

Hà, P. T. T., Phương, N. D., Tuấn, N. V., & Thiện, L. C. (2021) · Tạp chí Y học Việt Nam · doi:10.51298/vmj.v507i2.1446

Evaluation of Serotonin Serum Level in Cases of Alopecia Areata and Vitiligo

Mostafa, F. F., Khalifa, N., Ibrahim, S. M., & Shafy, A. S. A. (2022) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2022.215201

PSORIASIS AND PSYCHIC CONFLICTS IN ADULTHOOD: QUALITATIVE STUDY BASED ON ANALYTICAL PSYCHOLOGY

Dias, M. R. D. S. B., Vieira, C. M., Vanderlei, L. C. D. M., & Barbosa, L. N. F. (2022) · Psicologia Saúde & Doenças · doi:10.15309/22psd230324

Guía Esencial de Medicina Interna en el Primer Nivel de Atención Tomo 3

Barreiro, I. A. D., Andrade, J. E. G., Euvin, D. C., Solís, A. A. P., Toledo, M. A. T., & Garzón, J. A. R. (2023) · Juan Cuevas eBooks · doi:10.56470/978-9942-627-85-8

Rationality of Cytoflavin Inclusion in the Treatment of Patients with Dermatological Pathology Comorbid with Mental Disorders

Khaydarov, M., Коваленко, А. Л., Petrov, A. Y., & Khaidarova, N. (2023) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2023-68-5-6-49-54

Association between microbiome and psoriasis vulgaris and arthropathic psoriasis: a bidirectional two-sample Mendelian randomization studyPreprint

Zhang, J., Xiang, Y., Shen, Y., Chen, J., Liu, L., Liu, Q., Jin, J., & Zhu, S. (2023) · Research Square · doi:10.21203/rs.3.rs-3498980/v1

Prevalência de sintomas gastrointestinais em pacientes com psoríase e a utilização da calprotectina fecal como método de triagem para diagnóstico de doenças inflamatórias intestinais

Oliveira, A. H. K. (2021) · doi:10.47749/t/unicamp.2021.1243247

Análise do manejo de pacientes portadores de psoríase na rede de saúde do Sistema Único de Saúde (SUS): uma avaliação sobre a perspectiva dos atendimentos em um serviço de alta complexidade

Mumic, F. T. (2023) · doi:10.11606/d.17.2023.tde-15022024-160148

Well-Being in Psoriasis: Weighting its Components Using Best-worst Scaling Methodology

Daudén, E., Belinchón, I., Colominas-González, E., Coto, P., de la Cueva, P., Gallardo, F., Poveda, J. L., Herráiz, E. R., Ros, S., Ruíz‐Villaverde, R., et al. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01499-8

Dobrostan psychiczny, obraz ciała i interocepcja – różnice między kobietami z chorobami reumatologicznymi a kobietami zdrowymi

Krymow, N., Rumiński, J., Lewandowska, M., & Milner, R. (2025) · Przegląd Psychologiczny · doi:10.31648/przegldpsychologiczny.11503

Psoriasis and Comorbidities: What and How Much Do We Know?

Salihbegovic, E. M., Kurtalić, N., & Kurtalić, S. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1014677

Psychological Well-Being, Body Image, and Interoception – Differences Between Women With Rheumatologic Diseases and Healthy Women

Krymow, N., Rumiński, J. K., Lewandowska, M., & Milner, R. (2025) · Przegląd Psychologiczny · doi:10.31648/przegldpsychologiczny.12559

Multidisciplinary Management in Psoriasis: A Structured Approach for Early Comorbidity Detection and Referral

López‐Ferrer, A., González‐Cantero, Á., Gutiérrez-Casbas, A., Martorell, A., Olveira, A., Álvarez, M. B. M., Nicolau, J., Carrascosa, J. M., Baniandrés, O., Rivera, R., et al. (2026) · Dermatology and Therapy · doi:10.1007/s13555-026-01759-1

Psoriasis y depresión: el papel de la inflamación

González‐Parra, S., & Daudén, E. (2018) · Actas Dermo-Sifiliográficas · doi:10.1016/j.ad.2018.05.009 · Cited by 67 · see citing works

Depression and suicidality in psoriasis: review of the literature including the cytokine theory of depression

Koo, J. Y. M., Marangell, L. B., Nakamura, M., Armstrong, A. W., Jeon, C., Bhutani, T., & Wu, J. J. (2017) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.14460 · Cited by 209 · see citing works

Occurrence of depression in patients with psoriasis – the role of inflammation, stress and mechanism of the vicious circle

Kuchnicka, A. A., Zielińska, M., Kosz, K., Zarankiewicz, N., & Piecewicz‐Szczęsna, H. (2020) · Journal of Pre-Clinical and Clinical Research · doi:10.26444/jpccr/122221

Association Between Psoriasis and Depression: A Traditional Review

Sahi, F. M., Masood, A., Danawar, N. A., Mekaiel, A., & Malik, B. H. (2020) · Cureus · doi:10.7759/cureus.9708 · Cited by 75 · see citing works

Common Fundamentals of Psoriasis and Depression

Hölsken, S., Krefting, F., Schedlowski, M., & Sondermann, W. (2021) · Acta Dermato Venereologica · doi:10.2340/actadv.v101.565 · Cited by 59 · see citing works